www.fdanews.com/articles/147373-alnylam-gets-orphan-status-for-drug-candidate

Alnylam Gets Orphan Status for Drug Candidate

June 20, 2012

Alnylam Pharmaceuticals said Tuesday that it received special regulatory incentives for a drug designed to treat a potentially fatal neurodegenerative disease.
CBS News